1. Home
  2. BAFN vs PDSB Comparison

BAFN vs PDSB Comparison

Compare BAFN & PDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BAFN
  • PDSB
  • Stock Information
  • Founded
  • BAFN 1999
  • PDSB 2005
  • Country
  • BAFN United States
  • PDSB United States
  • Employees
  • BAFN N/A
  • PDSB N/A
  • Industry
  • BAFN Savings Institutions
  • PDSB Biotechnology: Pharmaceutical Preparations
  • Sector
  • BAFN Finance
  • PDSB Health Care
  • Exchange
  • BAFN Nasdaq
  • PDSB Nasdaq
  • Market Cap
  • BAFN 63.2M
  • PDSB 72.2M
  • IPO Year
  • BAFN N/A
  • PDSB N/A
  • Fundamental
  • Price
  • BAFN $11.90
  • PDSB $1.11
  • Analyst Decision
  • BAFN
  • PDSB Strong Buy
  • Analyst Count
  • BAFN 0
  • PDSB 2
  • Target Price
  • BAFN N/A
  • PDSB $10.00
  • AVG Volume (30 Days)
  • BAFN 15.6K
  • PDSB 402.8K
  • Earning Date
  • BAFN 07-29-2025
  • PDSB 08-13-2025
  • Dividend Yield
  • BAFN 2.61%
  • PDSB N/A
  • EPS Growth
  • BAFN 102.38
  • PDSB N/A
  • EPS
  • BAFN 1.90
  • PDSB N/A
  • Revenue
  • BAFN $78,211,000.00
  • PDSB N/A
  • Revenue This Year
  • BAFN N/A
  • PDSB N/A
  • Revenue Next Year
  • BAFN N/A
  • PDSB N/A
  • P/E Ratio
  • BAFN $6.44
  • PDSB N/A
  • Revenue Growth
  • BAFN 0.67
  • PDSB N/A
  • 52 Week Low
  • BAFN $11.90
  • PDSB $0.85
  • 52 Week High
  • BAFN $19.75
  • PDSB $4.29
  • Technical
  • Relative Strength Index (RSI)
  • BAFN 30.39
  • PDSB 39.41
  • Support Level
  • BAFN $12.15
  • PDSB $1.06
  • Resistance Level
  • BAFN $13.60
  • PDSB $1.15
  • Average True Range (ATR)
  • BAFN 0.50
  • PDSB 0.07
  • MACD
  • BAFN -0.26
  • PDSB 0.01
  • Stochastic Oscillator
  • BAFN 0.00
  • PDSB 36.14

About BAFN BayFirst Financial Corp.

BayFirst Financial Corp is a bank holding company, it generates its revenue from interest on loans and the gain-on-sale income derived from the sale of loans into the secondary market. The company serves a broad spectrum of individuals, families, and small businesses, supported by national business lines in residential and SBA lending and technology platforms. The primary source of funding for its loans is deposits. BayFirst measures performance through net interest income after provision for loan losses, return on average assets, and return on average common equity, while maintaining appropriate regulatory leverage and risk-based capital ratios. The company has various segment such as Real Estate(Residential, Commercial, and Construction & Land), Commercial and Industrial, Consumer.

About PDSB PDS Biotechnology Corporation

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.

Share on Social Networks: